3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Prostatic Neoplasms
4
Neoplasms
3
Colorectal Neoplasms
3
Lung Neoplasms
2
Gastrointestinal Neoplasms
2
Breast Neoplasms
2
Sarcoma
1
Rectal Neoplasms
1
Pancreatic Cancer Resectable
1
Lymphangioleiomyomatosis
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Gliosarcoma
1
Glioblastoma
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Central Nervous System Neoplasms
1
Carcinoma, Renal Cell
1
COVID-19
1
Breast Neoplasms, Male
1
Biliary Tract Neoplasms
1
Bile Duct Neoplasms
1
Arthritis, Rheumatoid
1
Anatomic Stage I Breast Cancer AJCC v8
1
Adenocarcinoma of Lung
1
Interventions
pembrolizumab
26
atezolizumab
14
Nivolumab
13
Gemcitabine
13
Cisplatin
10
Docetaxel
8
Carboplatin
8
avelumab
7
Mitomycin
7
epacadostat
4
cabozantinib
4
Ipilimumab
4
pemigatinib
3
Specimen Handling
3
Paclitaxel
3
Magnetic Resonance Spectroscopy
3
Bevacizumab
3
vofatamab
2
rucaparib
2
lenvatinib
2
enfortumab vedotin
2
durvalumab
2
cabazitaxel
2
bempegaldesleukin
2
Standard of Care
2
Rogaratinib
2
Ramucirumab
2
Radiation
2
Platinum
2
Pemetrexed
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Transitional Cell
×
Hydroxychloroquine
×
Clear all
No trials found.